Stimulation of Langerhans cells with ketoprofen plus UVA in murine photocontact dermatitis to ketoprofen

Journal of Dermatological Science

Volumn 47, Issue 2, 2007, Pages 151-159

  Atarashi, Kenji ^a,b   Kabashima, Kenji ^a   Akiyama, Katsuhiko ^b   Tokura, Yoshiki ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b HISAMITSU PHARMACEUTICAL CO INC   (Japan)

Author keywords

Ketoprofen; Langerhans cell; Maturation; Photocontact dermatitis

Indexed keywords

CD86 ANTIGEN; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; KETOPROFEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL STIMULATION; CELL STRUCTURE; CONTROLLED STUDY; DRUG MECHANISM; EPIDERMIS CELL; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LANGERHANS CELL; MOUSE; NONHUMAN; PHOTODERMATOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; REAL TIME POLYMERASE CHAIN REACTION; ULTRAVIOLET A RADIATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGENS, CD86; DERMATITIS, PHOTOALLERGIC; DISEASE MODELS, ANIMAL; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERLEUKIN-1ALPHA; KETOPROFEN; LANGERHANS CELLS; MICE; MICE, INBRED AKR; MICE, INBRED BALB C; SKIN; SPECIES SPECIFICITY; ULTRAVIOLET RAYS;

EID: 34249868465     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2007.04.001     Document Type: Article

References (36)

1. Cusano F., Rafenelli A., Bacchilega R., and Errico G. Photo-contact dermatitis from ketoprofen. Contact Dermatitis 17 (1987) 108-109
2. Nabeya R.T., Kojima T., and Fujita M. Photocontact dermatitis from ketoprofen with an unusual clinical feature. Contact Dermatitis 32 (1995) 52-53
3. Le Coz C.J., Bottlaender A., Scrivener J.N., Santinelli F., Cribier B.J., Heid E., et al. Photocontact dermatitis from ketoprofen and tiaprofenic acid: cross-reactivity study in 12 consecutive patients. Contact Dermatitis 38 (1998) 245-252
4. Sugiura M., Hayakawa R., Kato Y., Sugiura K., and Ueda H. 4 cases of photocontact dermatitis due to ketoprofen. Contact Dermatitis 43 (2000) 16-19
5. Matsushita T., and Kamide R. Five cases of photocontact dermatitis due to topical ketoprofen: photopatch testing and cross-reaction study. Photodermatol Photoimmunol Photomed 17 (2001) 26-31
6. Mozzanica N., and Pigatto P.D. Contact and photocontact allergy to ketoprofen: clinical and experimental study. Contact Dermatitis 23 (1990) 336-340
7. Sugiura M., Hayakawa R., Xie Z., Sugiura K., Hiramoto K., and Shamoto M. Experimental study on phototoxicity and the photosensitization potential of ketoprofen, suprofen, tiaprofenic acid and benzophenone and the photocross-reactivity in guinea pigs. Photodermatol Photoimmunol Photomed 18 (2002) 82-89
8. Iwamoto Y., Mifuchi I., and Yielding L.W. Photodynamic deoxyribonucleic acid strand breaking activities of enoxacin and afloqualone. Chem Pharm Bull 40 (1992) 1868-1870
9. Hashizume H., Tokura Y., Oku T., Iwamoto Y., Takigawa M., and Photodynamic. DNA-breaking activity of serum from patients with various photosensitivity dermatoses. Arch Dermatol Res 287 (1995) 586-590
10. Tokura Y. Quinolone photoallergy: photosensitivity dermatitis induced by systemic administration of photohaptenic drugs. J Dermatol Sci 18 (1998) 1-10
11. Tokura Y., Nishijima T., Yagi H., Furukawa F., and Takigawa M. Photohaptenic properties of fluoroquinolones. Photochem Photobiol 64 (1996) 838-844
12. Tokura Y., Seo N., Yagi H., Furukawa F., and Takigawa M. Cross-reactivity inmurine fluoroquinolone photoallergy: exclusive usage of TCR Vβ 13 by immune T cells that recognize fluoroquinolone-photomodified cells. J Immunol 160 (1998) 3719-3728
13. Tokura Y., Ogai M., Yagi H., and Takigawa M. Afloqualone photosensitivity: immunogenicity of afloqualone-photomodified epidermal cells. Photochem Photobiol 60 (1994) 262-267
14. Tokura Y. Immune responses to photohaptens: implications for the mechanisms of photosensitivity to exogenous agents. J Dermatol Sci 23 (2000) S6-S9
15. Tokura Y., Satoh T., Takigawa M., and Yamada M. Genetic control of contact photosensitivity to tetrachlorosalicylanilide. I. Preferential activation of suppressor T cells in low responder H-2k mice. J Invest Dermatol 94 (1990) 471-476
16. Nishijima T., Tokura Y., Imokawa G., and Takigawa M. Photohapten TCSA painting plus UVA irradiation of murine skin augments the expression of MHC class II molecules and CD86 on Langerhans cells. J Dermatol Sci 19 (1999) 202-207
17. Suzuki K., Yamazaki S., and Tokura Y. Expression of T-cell cytokines in challenged skin of murine allergic contact photosensitivity: low responsiveness is associated with induction of Th2 cytokines. J Dermatol Sci 23 (2000) 138-144
18. Gerberick G.F., Ryan C.A., Fletcher E.R., Howard A.D., and Robinson M.K. Increased number of dendritic cells in draining lymph nodes accompanies the generation of contact photosensitivity. J Invest Dermatol 96 (1991) 355-361
19. Lahoz A., Hernandez D., Miranda M.A., Perez-Prieto J., Morera I.M., and Castell J.V. Antibodies directed to drug epitopes to investigate the structure of drug-protein photoadducts. Recognition of a common photobound substructure in tiaprofenic acid/ketoprofen cross-photoreactivity. Chem Res Toxicol 14 (2001) 1486-1491
20. Tokura Y., Seo N., Fujie M., and Takigawa M. Quinolone-photoconjugated major histocompatibility complex class II-binding peptides with lysine are antigenic for T cells mediating murine quinolone photoallergy. J Invest Dermatol 117 (2001) 1206-1211
21. Aiba S., and Katz S.I. Phenotypic and functional characteristics of in vivo-activated Langerhans cells. J Immunol 145 (1990) 2791-2796
22. Rattis F.M., Peguet-Navarro J., Staquet M.J., Dezutter-Dambuyant C., Courtellemont P., Redziniak G., et al. Expression and function of B7-1 (CD80) and B7-2 (CD86) on human epidermal Langerhans cells. Eur J Immunol 26 (1996) 449-453
23. Chang C.H., Furue M., and Tamaki K. B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-gamma or by interleukin-10. Eur J Immunol 25 (1995) 394-398
24. Peguet-Navarro J., Dalbiez-Gauthier C., Rattis F.M., Van Kooten C., Banchereau J., and Schmitt D. Functional expression of CD40 antigen on human epidermal Langerhans cells. J Immunol 155 (1995) 4241-4247
25. Salgado C.G., Nakamura K., Sugaya M., Toda Y., Asahina A., and Fukuoka S. Differential effects of cytokines and immunosuppressive drugs on CD40, B7-1 and B7-2 expression on purified epidermal Langerhans cells. J Invest Dermatol 113 (1999) 1021-1027
26. Harber L.C., Harris H., and Baer R.L. Photoallergic contact dermatitis due to halogenated salicylanilides and related compounds. Arch Dermatol 94 (1966) 255-262
27. Epstein J.H., Wuepper K.D., and Maibach H.I. Photocontact dermatitis to halogenated salicylanilides and related compounds: a clinical and histological review of 26 patients. Arch Dermatol 97 (1968) 236-244
28. Witmer-Pack M.D., Oliver W., Valinsky J., Schuler G., and Steinman R.M. Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J Exp Med 166 (1987) 1484-1498
29. Heufler C., Koch F., and Schuler G. Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J Exp Med 167 (1988) 700-705
30. Nakae S., Naruse-Nakajima C., Sudo K., Horai R., Asano M., and Iwamoto Y. IL-1 alpha, but not IL-1 beta, is required for contact-allergen-specific T cell activation during the sensitization phase in contact hypersensitivity. Int Immunol 13 (2001) 1471-1478
31. Imai S., Atarashi K., Ikesue K., Akiyama K., and Tokura Y. Establishment of murine model of allergic photocontact dermatitis to ketoprofen and characterization of pathogenic T cells. J Dermatol Sci 41 (2006) 127-136
32. Tokura Y., Yagi J., O'Malley M., Lewis J.M., and Takigawa M. Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class II-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines. J Invest Dermatol 102 (1994) 31-38
33. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
34. Okamoto H., and Kripke M.L. Effector and suppressor circuits of the immune response are activated in vivo by different mechanisms. Proc Natl Acad Sci 84 (1987) 3841-3845
35. Hauser C., Elbe A., and Stingle G. The Langerhans cell. In: Goldsmith L.A. (Ed). Physiology, biochemistry, and molecular biology of the skin. 2nd ed. (1991), Oxford University Press, New York, NY pp. 1144-1163
36. Kabashima K., Sakata D., Nagamachi M., Miyachi Y., Inaba K., and Narumiya S. Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat Med 9 (2003) 744-749